Detailed information for compound 1233428

Basic information

Technical information
  • TDR Targets ID: 1233428
  • Name: N-(4-acetamidophenyl)-5-methyl-2-phenylpyrazo le-3-carboxamide
  • MW: 334.372 | Formula: C19H18N4O2
  • H donors: 2 H acceptors: 3 LogP: 2.64 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(=O)Nc1ccc(cc1)NC(=O)c1cc(nn1c1ccccc1)C
  • InChi: 1S/C19H18N4O2/c1-13-12-18(23(22-13)17-6-4-3-5-7-17)19(25)21-16-10-8-15(9-11-16)20-14(2)24/h3-12H,1-2H3,(H,20,24)(H,21,25)
  • InChiKey: OQOBQQNGAFERQA-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N-(4-acetamidophenyl)-5-methyl-2-phenyl-pyrazole-3-carboxamide
  • N-(4-acetamidophenyl)-5-methyl-2-phenyl-3-pyrazolecarboxamide
  • SMR000027797
  • MLS000089422
  • N-[4-(acetylamino)phenyl]-3-methyl-1-phenyl-1H-pyrazole-5-carboxamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references
Homo sapiens K(lysine) acetyltransferase 2A Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Plasmodium vivax histone acetyltransferase GCN5, putative Get druggable targets OG5_127781 All targets in OG5_127781
Loa Loa (eye worm) acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
Plasmodium yoelii histone acetyltransferase GCN5-related Get druggable targets OG5_127781 All targets in OG5_127781
Echinococcus granulosus histone acetyltransferase KAT2B Get druggable targets OG5_127781 All targets in OG5_127781
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis Get druggable targets OG5_127781 All targets in OG5_127781
Echinococcus granulosus histone acetyltransferase KAT2B Get druggable targets OG5_127781 All targets in OG5_127781
Plasmodium berghei histone acetyltransferase GCN5, putative Get druggable targets OG5_127781 All targets in OG5_127781
Theileria parva histone acetyltransferase Gcn5, putative Get druggable targets OG5_127781 All targets in OG5_127781
Toxoplasma gondii histone lysine acetyltransferase GCN5-B Get druggable targets OG5_127781 All targets in OG5_127781
Giardia lamblia Histone acetyltransferase GCN5 Get druggable targets OG5_127781 All targets in OG5_127781
Candida albicans bromodomain protein similar to S. cerevisiae GCN5 (YGR252W) histone acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
Neospora caninum Bromodomain containing protein, related Get druggable targets OG5_127781 All targets in OG5_127781
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 Get druggable targets OG5_127781 All targets in OG5_127781
Neospora caninum hypothetical protein Get druggable targets OG5_127781 All targets in OG5_127781
Brugia malayi acetyltransferase, GNAT family protein Get druggable targets OG5_127781 All targets in OG5_127781
Babesia bovis histone acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
Plasmodium falciparum histone acetyltransferase GCN5 Get druggable targets OG5_127781 All targets in OG5_127781
Toxoplasma gondii histone lysine acetyltransferase GCN5-A Get druggable targets OG5_127781 All targets in OG5_127781
Cryptosporidium parvum GCN5 like acetylase + bromodomain Get druggable targets OG5_127781 All targets in OG5_127781
Schistosoma japonicum ko:K06062 p300/CBP-associated factor, putative Get druggable targets OG5_127781 All targets in OG5_127781
Entamoeba histolytica acetyltransferase, GNAT family Get druggable targets OG5_127781 All targets in OG5_127781
Plasmodium knowlesi histone acetyltransferase GCN5, putative Get druggable targets OG5_127781 All targets in OG5_127781
Cryptosporidium hominis histone acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
Trichomonas vaginalis cat eye syndrome critical region protein 2, cscr2, putative Get druggable targets OG5_127781 All targets in OG5_127781
Trichomonas vaginalis bromodomain-containing protein, putative Get druggable targets OG5_127781 All targets in OG5_127781
Candida albicans bromodomain protein similar to S. cerevisiae GCN5 (YGR252W) histone acetyltransferase Get druggable targets OG5_127781 All targets in OG5_127781
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Wolbachia endosymbiont of Brugia malayi ferredoxin 0.0134 0.0201 0.5
Mycobacterium ulcerans aerobic-type carbon monoxide dehydrogenase subunit CoxM_2 0.1409 0.3293 0.4847
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0175 0.03 1
Plasmodium falciparum ferredoxin, putative 0.0134 0.0201 0.5
Leishmania major hypothetical protein, conserved 0.0134 0.0201 0.5
Mycobacterium ulcerans carbon monoxyde dehydrogenase large chain CoxL 0.1237 0.2876 0.4193
Mycobacterium ulcerans carbon monoxide dehydrogenase 0.2764 0.6582 1
Mycobacterium tuberculosis Probable carbon monoxyde dehydrogenase (small chain) 0.0797 0.1808 0.3614
Echinococcus granulosus histone acetyltransferase KAT2B 0.017 0.0288 1
Toxoplasma gondii ferredoxin, putative 0.0134 0.0201 1
Treponema pallidum quinoline 2-oxidoreductase 0.0662 0.1483 0.8682
Mycobacterium ulcerans aerobic-type carbon monoxide dehydrogenase subunit CoxL_2 0.1967 0.4649 0.6971
Trichomonas vaginalis Ferredoxin 4 0.0134 0.0201 0.0201
Trypanosoma brucei NADH-ubiquinone oxidoreductase complex I subunit, putative 0.0134 0.0201 0.5
Trichomonas vaginalis Ferredoxin 1 0.0134 0.0201 0.0201
Trichomonas vaginalis Ferredoxin 7 0.0134 0.0201 0.0201
Trichomonas vaginalis Ferredoxin 3 0.0134 0.0201 0.0201
Plasmodium falciparum adrenodoxin-type ferredoxin, putative 0.0134 0.0201 0.5
Brugia malayi acetyltransferase, GNAT family protein 0.0175 0.03 1
Chlamydia trachomatis ferredoxin 0.0134 0.0201 0.5
Toxoplasma gondii ferodoxin FD 0.0134 0.0201 1
Brugia malayi MH2 domain containing protein 0.0144 0.0225 0.2453
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis 0.0175 0.03 1
Treponema pallidum hypothetical protein 0.0678 0.1521 1
Onchocerca volvulus 0.0134 0.0201 0.5
Plasmodium vivax ferredoxin, putative 0.0134 0.0201 1
Onchocerca volvulus Adrenodoxin, mitochondrial homolog 0.0134 0.0201 0.5
Trypanosoma cruzi adrenodoxin precursor, putative 0.0134 0.0201 0.5
Giardia lamblia [2Fe-2S] ferredoxin 0.0134 0.0201 0.5
Leishmania major adrenodoxin-like protein,ferredoxin, 2fe-2s-like protein 0.0134 0.0201 0.5
Mycobacterium ulcerans carbon monoxyde dehydrogenase medium chain CoxM 0.1409 0.3293 0.4847
Loa Loa (eye worm) MH2 domain-containing protein 0.0144 0.0225 0.2453
Echinococcus granulosus Adrenodoxin mitochondrial 0.0134 0.0201 0.6968
Trypanosoma brucei electron transfer protein, putative 0.0134 0.0201 0.5
Mycobacterium ulcerans hypothetical protein 0.0678 0.1521 0.2069
Trypanosoma cruzi adrenodoxin precursor, putative 0.0134 0.0201 0.5
Leishmania major adrenodoxin-like protein,ferredoxin, 2fe-2s-like protein 0.0134 0.0201 0.5
Mycobacterium ulcerans carbon monoxyde dehydrogenase small chain CoxS 0.0797 0.1808 0.2519
Mycobacterium tuberculosis Probable carbon monoxyde dehydrogenase (medium chain) 0.1409 0.3293 0.6953
Trichomonas vaginalis Ferredoxin 6 0.0134 0.0201 0.0201
Toxoplasma gondii adrenodoxin-type ferredoxin, putative 0.0134 0.0201 1
Loa Loa (eye worm) transcription factor SMAD2 0.0144 0.0225 0.2453
Trichomonas vaginalis xanthine dehydrogenase, putative 0.4173 1 1
Leishmania major ferredoxin 2fe-2s-like protein 0.0134 0.0201 0.5
Trypanosoma cruzi adrenodoxin precursor, putative 0.0134 0.0201 0.5
Trichomonas vaginalis aldehyde oxidase, putative 0.4173 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0134 0.0201 0.5
Mycobacterium tuberculosis Probable carbon monoxyde dehydrogenase (large chain) 0.1967 0.4649 1
Chlamydia trachomatis Na(+)-translocating NADH-quinone reductase subunit F 0.0134 0.0201 0.5
Trichomonas vaginalis Ferredoxin 2 0.0134 0.0201 0.0201
Leishmania major ferredoxin, 2fe-2s-like protein 0.0134 0.0201 0.5
Echinococcus granulosus ferredoxin 0.0134 0.0201 0.6968
Mycobacterium ulcerans carbon monoxyde dehydrogenase large chain CoxL 0.1967 0.4649 0.6971
Loa Loa (eye worm) acetyltransferase 0.0175 0.03 1
Mycobacterium ulcerans carbon monoxyde dehydrogenase small chain CoxS 0.0797 0.1808 0.2519

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 0.4467 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) 11.2202 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398] ChEMBL. No reference
Potency (functional) = 39.8107 um PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 39.8107 um PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 112.2018 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.